ARBUCKLE STUART A 1557290 Data last updated 2024-05-14 07:02:16 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-01 | 2023-05-30 | 2023-05-30 | 4 | Arbuckle Stuart A | EVP, COO | dsp | 82.0 | 0.14 | 0.0 | 329.82 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code S | 56556.0 | 257.55 (VRTX) |
| 2023-06-01 | 2023-05-30 | 4 | Arbuckle Stuart A | EVP, COO | holding | 140.0 | 0 | 0.01 | 0.0 | 401(K) | Common Stock | VERTEX PHARMACEUTICALS INC / MA | NA | 257.55 (VRTX) | ||
| 2023-07-05 | 2023-06-30 | 2023-06-30 | 4 | Arbuckle Stuart A | DIRECTOR | acq | 695.0 | 16.9 | 0.03 | 18.87 | Direct | Common Stock | IMMUNOGEN, INC. | code A | 4112.0 | 226.07 (IMGN) |
| 2023-10-02 | 2023-09-29 | 2023-09-29 | 4 | Arbuckle Stuart A | DIRECTOR | acq | 827.0 | 16.74 | 0.03 | 15.87 | Direct | Common Stock | IMMUNOGEN, INC. | code A | 4939.0 | 248.94 (IMGN) |
| 2023-06-20 | 2023-06-15 | 4 | Arbuckle Stuart A | EVP, COO | holding | 140.0 | 0 | 0.01 | 0.0 | 401(K) | Common Stock | VERTEX PHARMACEUTICALS INC / MA | NA | 257.55 (VRTX) | ||
| 2023-06-20 | 2023-06-15 | 2023-06-15 | 4 | Arbuckle Stuart A | EVP, COO | dsp | 8603.0 | 13.2 | 0.33 | 349.0 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code S | 56556.0 | 257.55 (VRTX) |
| 2023-06-20 | 2023-06-15 | 2023-06-15 | 4 | Arbuckle Stuart A | EVP, COO | acq | 8603.0 | 13.2 | 0.33 | 187.53 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code M | 65159.0 | 257.55 (VRTX) |
| 2023-12-15 | 2023-12-13 | 4 | Arbuckle Stuart A | EVP, COO | holding | 140.0 | 0 | 0.01 | 0.0 | 401(K) | Common Stock | VERTEX PHARMACEUTICALS INC / MA | NA | 257.68 (VRTX) | ||
| 2023-12-15 | 2023-12-13 | 2023-12-13 | 4 | Arbuckle Stuart A | EVP, COO | acq | 8603.0 | 13.2 | 0.33 | 187.53 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code M | 65159.0 | 257.68 (VRTX) |
| 2023-12-15 | 2023-12-13 | 2023-12-13 | 4 | Arbuckle Stuart A | EVP, COO | dsp | 8603.0 | 13.2 | 0.33 | 399.0 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code S | 56556.0 | 257.68 (VRTX) |
| 2024-01-03 | 2023-12-29 | 2023-12-29 | 4 | Arbuckle Stuart A | DIRECTOR | acq | 442.0 | 8.21 | 0.02 | 29.65 | Direct | Common Stock | IMMUNOGEN, INC. | code A | 5381.0 | 266.26 (IMGN) |
| 2024-02-08 | 2024-02-06 | 2024-02-06 to 2024-02-07 | 4 | Arbuckle Stuart A | EVP, COO | acq | 26634.0 | 32.02 | 1.03 | 0.0 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code A | 83190.0
|
257.68 (VRTX) |
| 2024-02-08 | 2024-02-06 | 4 | Arbuckle Stuart A | EVP, COO | holding | 140.0 | 0 | 0.01 | 0.0 | 401(K) | Common Stock | VERTEX PHARMACEUTICALS INC / MA | NA | 257.68 (VRTX) | ||
| 2024-02-12 | 2024-02-12 | 2024-02-12 | 4 | Arbuckle Stuart A | DIRECTOR | dsp | 5381.0 | 100.0 | 0.2 | 0.0 | Direct | Common Stock | IMMUNOGEN, INC. | code D | 0.0 | 266.26 (IMGN) |
| 2024-02-13 | 2024-02-09 | 2024-02-09 to 2024-02-12 | 4 | Arbuckle Stuart A | EVP, COO | dsp | 7472.0 | 8.98 | 0.29 | 421.3 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code F S | 75718.0
|
257.68 (VRTX) |
| 2024-02-13 | 2024-02-09 | 4 | Arbuckle Stuart A | EVP, COO | holding | 140.0 | 0 | 0.01 | 0.0 | 401(K) | Common Stock | VERTEX PHARMACEUTICALS INC / MA | NA | 257.68 (VRTX) | ||
| 2024-02-21 | 2024-02-16 | 4 | Arbuckle Stuart A | EVP, COO | holding | 140.0 | 0 | 0.01 | 0.0 | 401(K) | Common Stock | VERTEX PHARMACEUTICALS INC / MA | NA | 258.31 (VRTX) | ||
| 2024-02-21 | 2024-02-16 | 2024-02-16 to 2024-02-20 | 4 | Arbuckle Stuart A | EVP, COO | dsp | 12676.0 | 16.74 | 0.49 | 421.88 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code F S | 63042.0
|
258.31 (VRTX) |
| 2024-02-23 | 2024-02-21 | 2024-02-21 | 4 | Arbuckle Stuart A | EVP, COO | dsp | 3603.0 | 5.72 | 0.14 | 421.77 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code S | 59439.0 | 258.31 (VRTX) |
| 2024-02-23 | 2024-02-21 | 4 | Arbuckle Stuart A | EVP, COO | holding | 140.0 | 0 | 0.01 | 0.0 | 401(K) | Common Stock | VERTEX PHARMACEUTICALS INC / MA | NA | 258.31 (VRTX) | ||
| 2024-02-27 | 2024-02-23 | 2024-02-23 to 2024-02-26 | 4 | Arbuckle Stuart A | EVP, COO | dsp | 9748.0 | 16.4 | 0.38 | 428.65 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code F S | 49691.0
|
258.31 (VRTX) |
| 2024-02-27 | 2024-02-23 | 4 | Arbuckle Stuart A | EVP, COO | holding | 140.0 | 0 | 0.01 | 0.0 | 401(K) | Common Stock | VERTEX PHARMACEUTICALS INC / MA | NA | 258.31 (VRTX) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-16 | 2023-06-14 | 2023-06-14 | 4 | Arbuckle Stuart A | DIRECTOR | acq | 13090.0 | 100.0 | 0.58 | 0.0 | Direct | Restricted Stock Unit | IMMUNOGEN, INC. | code A | 13090.0 | 226.07 (IMGN) |
| 2023-06-16 | 2023-06-14 | 2023-06-14 | 4 | Arbuckle Stuart A | DIRECTOR | acq | 19597.0 | 100.0 | 0.87 | 17.72 | Direct | Stock Option (Right To Buy) | IMMUNOGEN, INC. | code A | 19597.0 | 226.07 (IMGN) |
| 2023-06-23 | 2023-06-21 | 2023-06-21 | 4 | Arbuckle Stuart A | DIRECTOR | acq | 3000.0 | 100.0 | 0.53 | 0.0 | Direct | Restricted Stock Units | RHYTHM PHARMACEUTICALS, INC. | code A | 3000.0 | 56.85 (RYTM) |
| 2023-06-23 | 2023-06-21 | 2023-06-21 | 4 | Arbuckle Stuart A | DIRECTOR | acq | 14000.0 | 100.0 | 2.46 | 18.47 | Direct | Stock Option (Right To Buy) | RHYTHM PHARMACEUTICALS, INC. | code A | 14000.0 | 56.85 (RYTM) |
| 2023-06-20 | 2023-06-15 | 2023-06-15 | 4 | Arbuckle Stuart A | EVP, COO | dsp | 8603.0 | 50.0 | 0.33 | 187.53 | Direct | Stock Option (Right To Buy) | VERTEX PHARMACEUTICALS INC / MA | code M | 8603.0 | 257.55 (VRTX) |
| 2023-12-15 | 2023-12-13 | 2023-12-13 | 4 | Arbuckle Stuart A | EVP, COO | dsp | 8603.0 | 100.0 | 0.33 | 187.53 | Direct | Stock Option (Right To Buy) | VERTEX PHARMACEUTICALS INC / MA | code M | 0.0 | 257.68 (VRTX) |
| 2024-02-12 | 2024-02-12 | 2024-02-12 | 4 | Arbuckle Stuart A | DIRECTOR | dsp | 63000.0 | 100.0 | 2.37 | 0.0 | Direct | Deferred Share Unit | IMMUNOGEN, INC. | code D | 0.0 | 266.26 (IMGN) |
| 2024-02-12 | 2024-02-12 | 2024-02-12 | 4 | Arbuckle Stuart A | DIRECTOR | dsp | 213564.0 | 100.0 | 8.02 | 6.89 | Direct | Stock Option (Right To Buy) | IMMUNOGEN, INC. | code D | 0.0
|
266.26 (IMGN) |
| 2024-02-12 | 2024-02-12 | 2024-02-12 | 4 | Arbuckle Stuart A | DIRECTOR | dsp | 13090.0 | 100.0 | 0.49 | 0.0 | Direct | Restricted Stock Unit | IMMUNOGEN, INC. | code D | 0.0 | 266.26 (IMGN) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)